In addition, this study also offers proof-of-concept evidence for selectively inducing apoptosis by TFIIS.h upon p53 activation, providing a potentially novel target for future identification and development of new therapies for chemo-resistant cancers. This evidence concerns the gene TCEA2 and cancer.